- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Immobilier
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Insight 3693 results
COVID-19 Vaccine Updates
mars 8, 2021
UK Government considers allowing businesses to demand proof of COVID-19 vaccinations or negative test results
Thought Leadership
Client Alert
mars 8, 2021
What Happened to My Interest Rate? Fed Intensifies Scrutiny of Lenders' SOFR Transition Efforts
COVID-19 Vaccine Updates
mars 4, 2021
EU Blocks Export of COVID-19 Vaccine Doses to Australia
Client Alert
Client Alert
mars 4, 2021
Communicating with Employees through their Personal Devices
Client Alert
mars 4, 2021
FTC Drops Philadelphia-area Hospital Merger Challenge
Client Alert
mars 4, 2021
Reform to Mexican Electricity Law to Come into Effect
Article
mars 3, 2021
Biden Administration Reviewing Medicaid Work Requirements in Georgia and Other States
COVID-19 Vaccine Updates
mars 3, 2021
European Commission Announces Proposal for Digital Vaccination Pass to Permit Travel for Work and Tourism
Client Alert
mars 3, 2021
The Spanish Constitutional Court Bolsters Arbitration in Spain
COVID-19 Vaccine Updates
mars 2, 2021
White House Invokes the Defense Production Act to Accelerate Johnson & Johnson Vaccine Production